Issues
September 2009 EDITORIAL
- Designing Programs for Populations with Chronic Care Needs: A Blanket or a Quilt?
Jaan Sidorov, MD, MHSA Health policy must promote the ability of smaller systems to use sophisticated, rigorous, and less-than-perfect study designs to evaluate the impact of their local programs.  Full Text PDF DIABETES FOCUS
- Effect of a Managed Care Disease Management Program on Diabetes Care
Laura N. McEwen, PhD; Victoria C. Hsiao, MD, PhD; Elizabeth M. Nota-Kirby, MS; Gloria J. Kulpa, RN; Karen G. Schmidt, MPH; and William H. Herman, MD, MPH Processes and outcomes of diabetes care improved substantially over 6 years in a managed care health plan with a comprehensive diabetes disease management program.
- Prior Authorization to Improve Testing of Glycosylated Hemoglobin in a Managed Care Setting
Natan R. Kahan, PhD, RPh, MHA; Dan-Andrei Waitman, MD, MPH; Shimon Blackman, BS (Pharm); and Daniel A. Vardy, MD, MSc Prior authorization was successfully implemented in a managed care setting to obtain 100.0% performance of A1C testing in patients with diabetes treated with expensive drugs.
- Diabetes Care Quality: Insurance, Health Plan, and Physician Group Contributions
Gail M. Amundson, MD; Patrick J. O'Connor, MD, MPH; Leif I. Solberg, MD; Stephen E. Asche, MA; Rachel C. Woods; Emily D. Parker, PhD; and A. Lauren Crain, PhD Reporting physician group performance in addition to health plan performance may stimulate greater improvement in diabetes care.
- Type 2 Diabetes Mellitus in China: A Preventable Economic Burden
Weibing Wang, MD, PhD; William P. McGreevey, PhD; Chaowei Fu, MD, MSc; Siyan Zhan, MD, PhD; Rongsheng Luan, MD, PhD; Weiqing Chen, MD, PhD; and Biao Xu, MD, PhD, MPH Treatment of type 2 diabetes mellitus and its complications places a heavy burden on healthcare budgets in China and will continue to do so.
- Cost-Effectiveness of Roux-en-Y Gastric Bypass in Type 2 Diabetes Patients
Sayeed Ikramuddin, MD; C. David Klingman, PhD; Therese Swan, BA; Michael E. Minshall, MPH A predictive health economic model indicated that Roux-en-Y gastric bypass is cost-effective in the treatment of type 2 diabetes mellitus compared with medical management. MANAGERIAL
- Suboptimal Identification of Obesity by Family Physicians
Osnat C. Melamed, MD, MSc; Sasson Nakar, MD; and Shlomo Vinker, MD Family physicians failed to identify most obese and overweight patients, as seen by lack of body mass index documentation and concordant medical diagnoses. METHODS
- Patient Adherence: A Blind Spot in Cost-Effectiveness Analyses?
Allison B. Rosen, MD, MPH, ScD; Alicen B. Spaulding, MPH; Dan Greenberg, PhD; Jennifer A. Palmer, MS; and Peter J. Neumann, ScD A systematic literature review from 1998 to 2003 showed that few cost-effectiveness analyses of self-administered medications model suboptimal medication adherence. CLINICAL
- Toyota Production System Quality Improvement Initiative Improves Perioperative Antibiotic Therapy
Kelly H. Burkitt, PhD; Maria K. Mor, PhD; Rajiv Jain, MD; Matthew S. Kruszewski, PharmD; Ellesha E. McCray, MSN, RN, MBA; Michael E. Moreland, MSW; Robert R. Muder, MD; David Scott Obrosky, MS; Mary Ann Sevick, ScD, RN;
Mark A. Wilson, MD, PhD; and Michael J. Fine, MD, MSc Use of Toyota production system methods as part of a nosocomial MRSA prevention initiative on a surgical unit improved quality of care in other areas. TRENDS FROM THE FIELD
- Medicare Part D: Selected Issues for Plan Sponsors, Pharmacists, and Beneficiaries in 2009
JoAnn Stubbings, RPh, MHCA; and Ronnie J. DePue, Jr, PharmD Various changes to the Part D benefit were made in 2009, including availability of the data for research and increased cost of the standard benefit. LETTERS TO THE EDITORS
- Are There Unintended Consequences of Step-Therapy Programs?
Emily R. Cox, RPh, PhD and Brian J. Seiz, PharmD. Reply by Tami L. Mark, PhD, MBA; Teresa B. Gibson, PhD; and Kimberly A. McGuigan, PhD
Full Text PDF WEB EXCLUSIVE
- Patient-Centered Medical Home Demonstration: A Prospective, Quasi-Experimental, Before and After Evaluation
Robert J. Reid, MD, PhD; Paul A. Fishman, PhD; Onchee Yu, MS; Tyler R. Ross, MA; James T. Tufano, MHA, PhD; Michael P. Soman, MD, MPH; and Eric B. Larson, MD, MPH A 12-month evaluation of a patient-centered medical home demonstration indicated improvement in quality of care without an increase in overall costs.
|
|
